Jeremy Davis - Dec 20, 2022 Form 4 Insider Report for STANDARD BIOTOOLS INC. (LAB)

Role
SVP Chief Commercial Officer
Signature
/s/ Jeremy Davis
Stock symbol
LAB
Transactions as of
Dec 20, 2022
Transactions value $
$0
Form type
4
Date filed
1/20/2023, 04:24 PM
Previous filing
Apr 21, 2022
Next filing
Feb 23, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LAB Restricted Stock Units Award $0 +250K $0.00 250K Dec 20, 2022 Common Stock 250K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of LAB common stock.
F2 The restricted stock units vest in quarterly installments over the course of four years commencing February 20, 2023.